Relay Therapeutics, Inc. (RLAY)

17.80 +0.33 (+1.89%) USD  |  NASDAQ  |  Sep 28, 15:05
More

Relay Therapeutics Cash from Operations (Annual) : -235.46M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 -235.46M
December 31, 2024 -249.11M
December 31, 2023 -300.32M
December 31, 2022 -229.49M
Date Value
December 31, 2021 -74.41M
December 31, 2020 -102.49M
December 31, 2019 -66.13M
December 31, 2018 -44.14M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. -28.39M
Karyopharm Therapeutics, Inc. -75.37M
Spyre Therapeutics, Inc. -169.41M
Akebia Therapeutics, Inc. 67.99M
ACADIA Pharmaceuticals, Inc. 109.84M